[Osteogenesis imperfecta. Review of therapeutic methods].
D001205:Ascorbic Acid / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D002392:Catechin / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008277:Magnesium Oxide / Q000627:therapeutic use; D010013:Osteogenesis Imperfecta / Q000188:drug therapy*; D012969:Sodium Fluoride / Q000627:therapeutic use
D006728:Hormones; D002762:Cholecalciferol; D008277:Magnesium Oxide; D002392:Catechin; D012969:Sodium Fluoride; D002116:Calcitonin; D001205:Ascorbic Acid; D002118:Calcium
Wrodzona łamliwość kości (osteogenesis imperfecta). Przeglad pród leczenia.